BIC (BB) investor relations material

Opening remarks and agenda

• The meeting was opened by Chair Édouard Bich and CEO Rob Versloot, introducing new leadership and outlining the agenda, which included financial review, governance, sustainable development, and Q&A.

Financial performance review

• 2025 net sales were EUR 2,090 million, down 0.9% like-for-like; organic growth declined 4.7%.

• Adjusted EBIT margin was 13.6% (EUR 283 million); adjusted EPS was EUR 4.74, and free cash flow reached EUR 222 million.

• Net income group share dropped to EUR 86 million, impacted by non-recurring items from asset disposals and business discontinuations.

• Q1 2026 net sales grew 1.6% organically, with strong performance in North America and Tangle Teezer.

• Divisional performance: Human Expression EUR 736 million (-6.3%), Flame for Life EUR 723 million (-6.7%), Blade Excellence EUR 602 million (+15.7%) driven by Tangle Teezer.

Board and executive committee updates

• Rob Versloot was appointed CEO in September 2025, following a structured succession process.

• The board comprises 12 directors, including four independents and two employee representatives, with 40%–60% women.

• Several new directors were co-opted and their appointments ratified, including Rob Versloot as CEO and board member.

• Executive Committee renewed, reinforcing governance and organizational structure.

• The board held 13 meetings in 2025 with a 93% attendance rate, focusing on strategy, financials, and governance transition.